Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency

New England Journal of Medicine

Volumn 340, Issue 7, 1999, Pages 508-516

  Buckley, Rebecca H ^a   Schiff, Sherrie E ^a   Schiff, Richard I ^a   Louise Markert, M ^a   Williams, Larry W ^a   Roberts, Joseph L ^a   Myers, Laurie A ^a   Ward, Frances E ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CYCLOSPORIN; IMMUNOGLOBULIN;

ARTICLE; COMBINED IMMUNODEFICIENCY; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA MATCHING; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFANT; LYMPHOCYTE DEPLETION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; T LYMPHOCYTE;

B-LYMPHOCYTES; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY TESTING; HUMANS; INFANT; INFANT, NEWBORN; KILLER CELLS, NATURAL; LYMPHOCYTE DEPLETION; MALE; PHENOTYPE; PROSPECTIVE STUDIES; SEVERE COMBINED IMMUNODEFICIENCY; SURVIVAL ANALYSIS; T-LYMPHOCYTES;

EID: 0033580206     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199902183400703     Document Type: Article

References (44)

1. Bortin MM, Rimm AA. Severe combined immunodeficiency disease: characterization of the disease. and results of transplantation. JAMA 1977; 238:591-600.
2. Fischer A. Severe combined immunodeficiencies. Immunodefic Rev 1992;3:83-100.
3. Primary immunodeficiency diseases: report of a WHO scientific group. Clin Exp Immunol 1997;109:Suppl:1-28.
4. Buckley RH, Schiff RI, Schiff SE, et al. Human severe combined immunodeficiency: genetic, phenotypic, and functional diversity in one hundred eight infants. J Pediatr 1997;130:378-87.
5. Dausset J. Iso-leuco-anticorps. Acta Haematol 1958;20:156-66.
6. Amos DB, Bach FH. Phenotypic expressions of the major histocompatibility locus in man (HL-A): leukocyte antigens and mixed leukocyte culture reactivity. J Exp Med 1968;128:623-37.
7. Gatti RA, Meuwissen HJ, Allen HD, Hong R, Good RA. Immunological reconstitution of sex-linked lymphopenic immunological deficiency. Lancet 1968;2:1366-9.
8. Muller-Ruchholtz W, Wottge HU, Muller-Hermelink HK. Bone marrow transplantation in rats across strong histocompatibility barriers by selective elimination of lymphoid cells in donor marrow. Transplant Proc 1976;8: 537-41.
9. Reisner Y, Itzicovitch L, Meshorer A, Sharon N. Hemopoietic stem cell transplantation using mouse bone marrow and spleen cells fractionated by lectins. Proc Natl Acad Sci U S A 1978;75:2933-6.
10. Reisner Y, Kapoor N, Kirkpatrick D, et al. Transplantation for severe combined immunodeficiency with HLA-A,B,D,DR incompatible parental marrow cells fractionated by soybean agglutinin and sheep red blood cells. Blood 1983;61:341-8.
11. Friedrich W, Goldmann SF, Ebell W, et al. Severe combined immunodeficiency: treatment by bone marrow transplantation in 15 infants using HLA-haploidentical donors. Eur J Pediatr 1985;144:125-30.
12. Buckley RH, Schiff SE, Sampson HA, et al. Development of immunity in human severe primary T cell deficiency following haploidentical bone marrow stem cell transplantation. J Immunol 1986;136:2398-407.
13. O'Reilly RJ, Brochstein J, Collins N, et al. Evaluation of HLA-haplo-type disparate parental marrow grafts depleted of T lymphocytes by differential agglutination with a soybean lectin and E-rosette depletion for the treatment of severe combined immunodeficiency. Vox Sang 1986;51:Suppl 2:81-6.
14. Moen RC, Horowitz SD, Sondel PM, et al. Immunologic reconstitution after haploidentical bone marrow transplantation for immune deficiency disorders: treatment of bone marrow cells with monoclonal antibody CT-2 and complement. Blood 1987;70:664-9.
15. O'Reilly RJ, Keever CA, Small TN, Brochstein J. The use of HLA-non-identical T-cell-depleted marrow transplants for correction of severe combined immunodeficiency disease. Immunodefic Rev 1989;1:273-309.
16. Wijnaendts L, Le Deist F, Griscelli C, Fischer A. Development of immunologic functions after bone marrow transplantation in 33 patients with severe combined immunodeficiency. Blood 1989;74:2212-9.
17. Fischer A, Landais P, Friedrich W, et al. European experience of bone-marrow transplantation for severe combined immunodeficiency. Lancet 1990;336:850-4.
18. Dror Y, Gallagher R, Wara DW, et al. Immune reconstitution in severe combined immunodeficiency disease after lectin-treated, T cell depleted haplocompatible bone marrow transplantation. Blood 1993;81:2021-30.
19. Stephan JL, Vlekova V, Le Deist F, et al. Severe combined immunodeficiency: a retrospective single-center study of clinical presentation and outcome in 117 patients. J Pediatr 1993;123:564-72.
20. Giri N, Vowels M, Ziegler JB, Ford D, Lam Po-Tang R. HLA non-identical T-cell-depleted bone marrow transplantation for primary immunodeficiency diseases. Aust N Z J Med 1994;24:26-30.
21. Buckley RH. Bone marrow transplantation in primary immunodeficiency. In: Rich RR, ed. Clinical immunology: principles and practice. St. Louis: Mosby-Year Book, 1996:1813-30.
22. Noguchi M, Yi H, Rosenblatt HM, et al. Interleukin-2 receptor gamma chain mutation results in X-linked severe combined immunodeficiency in humans. Cell 1993;73:147-57.
23. Puck JM, Deschenes SM, Porter JC, et al. The interleukin-2 receptor gamma chain maps to Xq13.1 and is mutated in X-linked severe combined immunodeficiency, SCIDX1. Hum Mol Genet 1993;2:1099-104.
24. Puck JM. Molecular and genetic basis of X-linked immunodeficiency disorders. J Clin Immunol 1994;14:81-9.
25. Macchi P, Villa A, Gillani S, et al. Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID). Nature 1995; 377:65-8.
26. Russell SM, Tayebi N, Nakajima H, et al. Mutation of Jak3 in a patient with SCID: essential role of Jak3 in lymphoid development. Science 1995; 270:797-800.
27. Puel A, Ziegler SF, Buckley RH, Leonard WJ. Defective IL7R expression in T(-)B(+)NK(+) severe combined immunodeficiency. Nat Genet 1998;20:394-7.
28. Hirschhorn R. Overview of biochemical abnormalities and molecular genetics of adenosine deaminase deficiency. Pediatr Res 1993;33:Suppl: S35-S41.
29. Buckley RH, Dees SC, O'Fallon WM. Serum immunoglobulins. I. Levels in normal children and in uncomplicated childhood allergy. Pediatrics 1968;41:600-11.
30. Buckley RH, Fiscus SA. Serum IgD and IgE concentrations in immunodeficiency diseases. J Clin Invest 1975;55:157-65.
31. Buckley RH, Dees SC. Serum immunoglobulins. III. Abnormalities associated with chronic urticaria in children. J Allergy 1967;40:294-303.
32. van den Berg H, Vossen JM, Langlois van den Bergh R, Bayer J, van Tol MJD. Detection of Y chromosome by in situ hybridization in combination with membrane antigens by two-color immunofluorescence. Lab Invest 1991;64:623-8.
33. Schiff SE, Kurtzberg J, Buckley RH. Studies of human bone marrow treated with soybean lectin and sheep erythrocytes: stepwise analysis of cell morphology, phenotype and function. Clin Exp Immunol 1987;68:685-93.
34. Przepiorka D, Weisdorf D, Martin P, et al. 1994 Consensus conference on acute GVHD grading. Bone Marrow Transplant 1995;15:825-8.
35. Altman PL. Blood leukocyte values: man. I. Birth to maturity. In: Altman PL, Dittmer DS, eds. Blood and other body fluids. Bethesda, Md.: Federation of American Societies for Experimental Biology, 1961:125-6.
36. Ghory P, Schiff S, Buckley R. Appearance of multiple benign paraproteins during early engraftment of soy lectin T cell-depleted haploidentical bone marrow cells in severe combined immunodeficiency. J Clin Immunol 1986;6:161-9.
37. Kent EF Jr, Crawford J, Cohen HJ, Buckley RH. Development of multiple monoclonal serum immunoglobulins (multiclonal gammopathy) following both HLA-identical unfractionated and T cell-depleted haploidentical bone marrow transplantation in severe combined immunodeficiency. J Clin Immunol 1990;10:106-14.
38. Gerritsen EJA, van Tol MJD, Lankester AC, et al. Immunoglobulin levels and monoclonal gammopathies in children after bone marrow transplantation. Blood 1993;82:3493-502.
39. Clement-De Boers A, Oostdijk W, van Weel-Sipman MH, Van den Broeck J, Wit JM, Vossen JM. Final height and hormonal function after bone marrow transplantation in children. J Pediatr 1996;129:544-50.
40. Haddad E, Landais P, Friedrich W, et al. Long-term immune reconstitution and outcome after HLA-nonidentical T-cell-depleted bone marrow transplantation for severe combined immunodeficiency: a European retrospective study of 116 patients. Blood 1998;91:3646-53.
41. Kurtzberg J, Laughlin M, Graham ML, et al. Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. N Engl J Med 1996;335:157-66.
42. Gluckman E, Rocha V, Boyer-Chammard A, et al. Outcome of cord-blood transplantation from related and unrelated donors. N Engl J Med 1997;337:373-81.
43. Flake AW, Roncarolo M-G, Puck JM, et al. Treatment of X-linked severe combined immunodeficiency by in utero transplantation of paternal bone marrow. N Engl J Med 1996;335:1806-10.
44. Wengler GS, Lanfranchi A, Frusca T, et al. In-utero transplantation of parental CD34 haematopoietic progenitor cells in a patient with X-linked severe combined immunodeficiency (SCIDXI). Lancet 1996; 348:1484-7.